We are live on ! Find out more
TLP

Tri Locum Partners Portfolio holdings

AUM $713M
1-Year Est. Return 68.92%
This Fund
S&P 500
This Quarter Est. Return
+18.45%
1 Year Est. Return
+68.92%
3 Year Est. Return
+377.81%
5 Year Est. Return
+1,289.15%
10 Year Est. Return
–
AUM
$364M
AUM Growth
+$120M
Cap. Flow
+$104M
Cap. Flow %
28.62%
Top 10 Hldgs %
53.87%
Holding
72
New
21
Increased
11
Reduced
9
Closed
31

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$19.9M
2
BIIB icon
Biogen
BIIB
+$19.2M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$19M
4
GSK icon
GSK
GSK
+$15.5M
5
CTLT
CATALENT, INC.
CTLT
+$12.6M

Top Sells

Rank Stock Value
1
CCXI
ChemoCentryx, Inc.
CCXI
+$13.5M
2
EVH icon
Evolent Health
EVH
+$9.98M
3
BLU
BELLUS Health Inc.
BLU
+$9.77M
4
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$8.88M
5
TCDA
Tricida, Inc. Common Stock
TCDA
+$7.08M

Sector Composition

Rank Sector Weight
1 Healthcare 93.38%
2 Consumer Staples 2.67%
3 Financials 0.17%
4 Industrials 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EOLS icon
51
Evolus
EOLS
$472M
– –
-217,767
Closed -$2.53M
EVH icon
52
Evolent Health
EVH
$429M
– –
-324,869
Closed -$9.98M
MMM icon
53
3M
MMM
$92.8B
– –
-1,936
Closed -$210K
NG icon
54
NovaGold Resources
NG
$3.03B
– –
-11,433
Closed -$55K
NKTR icon
55
Nektar Therapeutics
NKTR
$2.49B
– –
-893
Closed -$51K
NLY icon
56
Annaly Capital Management
NLY
$17B
– –
-4,417
Closed -$104K
RIG icon
57
Transocean
RIG
$5.81B
– –
-19,683
Closed -$66K
RVMD icon
58
Revolution Medicines
RVMD
$41.8B
– –
-148,453
Closed -$2.89M
SKIL icon
59
Skillsoft
SKIL
$71.9M
– –
-545
Closed -$38K
STTK icon
60
Shattuck Labs
STTK
$685M
– –
-13,230
Closed -$54K
TVTX icon
61
Travere Therapeutics
TVTX
$6.06B
– –
-162,014
Closed -$3.93M
UP icon
62
Wheels Up
UP
$196M
– –
-99
Closed -$39K
MKFG
63
DELISTED
Markforged Holding Corporation
MKFG
– –
-1,759
Closed -$33K
ITCI
64
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-111,572
Closed -$6.37M
GATO
65
DELISTED
Gatos Silver, Inc.
GATO
– –
-12,062
Closed -$35K
LEV
66
DELISTED
The Lion Electric Company
LEV
– –
-10,466
Closed -$44K
ME
67
DELISTED
23andMe Holding Co
ME
– –
-718
Closed -$36K
SNCE
68
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
– –
-51,810
Closed -$2.08M
DOMA
69
DELISTED
Doma Holdings, Inc.
DOMA
– –
-879
Closed -$23K
TCDA
70
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-731,142
Closed -$7.08M
CCXI
71
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-545,532
Closed -$13.5M
HZNP
72
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-68,750
Closed -$5.48M
1 2
3

Similar funds

DCM
Defilade Capital Management Emeryville, California $712M AUM
AMPWP
Alvarez & Marsal Private Wealth Partners West Palm Beach, Florida $712M AUM
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
PCS
Personal CFO Solutions Chester, New Jersey $712M AUM 25.3% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ECM
EagleClaw Capital Management Boston, Massachusetts $714M AUM 24.24% 1-Year Est. Return

Tri Locum Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Tri Locum Partners held 72 positions worth $364M, up 49% from $244M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tri Locum Partners deployed $104M of net new capital in Q3 2022, opening 21 new positions and adding to 11 existing holdings. Its largest new stake was Neurocrine Biosciences: 196,390 shares worth $20.9M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 89% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was BELLUS Health Inc., an estimated $9.77M trimmed.

  • Tri Locum Partners's largest Q3 2022 buy was Neurocrine Biosciences: 196,390 shares worth $20.9M.
  • Tri Locum Partners added most to CATALENT, INC. in Q3 2022, an estimated $12.6M increase.
  • Tri Locum Partners's biggest Q3 2022 reduction was BELLUS Health Inc., cutting an estimated $9.77M.
  • Tri Locum Partners fully exited ChemoCentryx, Inc. in Q3 2022, selling an estimated $13.5M.
  • Tri Locum Partners's ten largest holdings make up 54% of its $364M portfolio in Q3 2022.
  • Tri Locum Partners opened 21 new positions and closed 31 in Q3 2022.
  • Tri Locum Partners's portfolio value rose 49% quarter-over-quarter to $364M.

Based on Tri Locum Partners's 13F filing for Q3 2022, filed 14 Nov 2022.